Katsumasa Nonoshita

This inventor holds 14 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Banyu Pharmaceutical Co. Ltd, Msd K.k., Taiho Pharmaceutical Company Limited. Active years: 1995-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsumasa Nonoshita. Retrieved from https://idiyas.com/inventor/katsumasa-nonoshita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 2)

% Patents Active = 92.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 5.3

ph-index = 4

Forward Citations = 50(Granted Patents)

Location History:

Ibaraki, JP (2010)
Tsukuba, JP (1995 - 2017)

Company Filing History:

8 out of 237

Banyu Pharmaceutical Co. Ltd

Taiho Pharmaceutical Company Limited

patents

Years Active: 1995-2017

Loading Chart...

Areas of Expertise:

Quinoline Compounds

Aminopyridine Derivatives

Heterocyclic Compounds

Benzimidazole Derivatives

Spiro Compounds

Amic Acid Derivatives

Squalene Epoxidase Inhibition

Condensed-Ring Compounds

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9758526 - Quinoline-substituted compound (2017-09-12),

2. 9650386 - Quinoline-substituted compound (2017-05-16),

3. 8889666 - Quinolyl pyrrolo pyrimidyl condensed-ring compound and salt thereof (2014-11-18),

4. 8519136 - Aminopyridine derivatives having aurora a selective inhibitory action (2013-08-27),

5. 8101621 - Aminopyridine derivatives having aurora a selective inhibitory action (2012-01-24),

6. 7994331 - Heterocycle-substituted benzimidazole derivative (2011-08-09),

7. 7915263 - Aminopyridine derivatives having aurora A selective inhibitory action (2011-03-29),

8. 7728025 - 2-heteroaryl-substituted benzimidazole derivative (2010-06-01),

9. 7205417 - Spiro compounds (2007-04-17),

10. 5777150 - Substituted amic acid derivatives (1998-07-07),

11. 5616803 - Substituted amic acid derivatives (1997-04-01),

12. 5606101 - Substitute amic acid derivatives (1997-02-25),

13. 5488149 - Substituted amic acid derivatives (1996-01-30),

14. 5444084 - Substituted heterocyclic derivative having squalene epoxidase inhibition (1995-08-22),

Title: **Inventor Katsumasa Nonoshita: Pioneering Innovations in Cancer Treatment**

Introduction

Katsumasa Nonoshita, an accomplished inventor based in Tsukuba, Japan, has made significant contributions to the field of pharmaceuticals, particularly in developing innovative compounds that target cancer treatment. With an impressive portfolio of 14 patents to his name, Nonoshita exemplifies the blend of creativity and scientific rigor that characterizes top inventors in the pharmaceutical industry.

Latest Patents

Among his most recent patents is a novel quinoline-substituted compound. The objective of this invention is to provide a compound with potent epidermal growth factor receptor (EGFR) inhibitory effects, which is crucial in curtailing cell growth and presenting potential as a medication for the prevention and treatment of various cancers. This advancement offers promising alternatives in the pursuit of more effective cancer therapies.

Career Highlights

Nonoshita has worked with notable companies in the pharmaceutical industry, including Banyu Pharmaceutical Co., Ltd. and Taiho Pharmaceutical Company Limited. His experience in these organizations has enriched his understanding and application of innovative science, enabling him to propel his inventions forward.

Collaborations

Throughout his career, Nonoshita has collaborated with esteemed colleagues such as Takashi Nomoto and Masahiro Hayashi. These partnerships have facilitated knowledge exchange and propelled the research and development of groundbreaking therapeutic compounds.

Conclusion

Katsumasa Nonoshita has solidified his position as a vital contributor to cancer research through his inventions. With a robust track record of patents and collaborations, he continues to inspire future generations of inventors aiming to make a tangible difference in the medical field. His work serves as a reminder of the vital role that innovation plays in helping humanity combat one of its most formidable challenges: cancer.

Profile summary based on public USPTO records.